Sign up to save your podcasts
Or
Share The Future of MS Management: Novel Agents and Clinical Approaches
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Future of MS Management: Novel Agents and Clinical Approaches
Guest: Marisa McGinley, DO
The multiple sclerosis (MS) treatment landscape is rapidly evolving, with novel approaches on the horizon that may transform care for progressive patients. Explore the latest phase 3 data on BTK inhibitors like tolebrutinib and gain insights into ongoing CAR T-cell and remyelination research, including the BEAT-MS trial, with Dr. Marisa McGinley, a neurologist at the Cleveland Clinic.
View all episodes
By ReachMDGuest: Marisa McGinley, DO
The multiple sclerosis (MS) treatment landscape is rapidly evolving, with novel approaches on the horizon that may transform care for progressive patients. Explore the latest phase 3 data on BTK inhibitors like tolebrutinib and gain insights into ongoing CAR T-cell and remyelination research, including the BEAT-MS trial, with Dr. Marisa McGinley, a neurologist at the Cleveland Clinic.